GALDERMA RESEARCH DEVELOPMENT; Patent Issued for Administration of 6[3-(1-Adamantyl)-4-Methoxyphenyl...
GALDERMA RESEARCH DEVELOPMENT; Patent Issued for Administration of 6[3-(1-Adamantyl)-4-Methoxyphenyl]-2-Naphthoic Acid for the Treatment of Dermatological Disorders (USPTO 9387187)
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Graeber, Michael (Lawrenceville, NJ); Czernielewski, Janusz (Biot, FR), filed on April 28, 2014, was published online on July 12, 2016 (see also [http://www.newsrx.com/search/topics/GALDERMA+RESEARCH+%26amp%3Bamp%3B+DEVELOPMENT] GALDERMA RESEARCH & DEVELOPMENT)....
Alternative Titles
Full title
GALDERMA RESEARCH DEVELOPMENT; Patent Issued for Administration of 6[3-(1-Adamantyl)-4-Methoxyphenyl]-2-Naphthoic Acid for the Treatment of Dermatological Disorders (USPTO 9387187)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1805859445
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1805859445
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
